136 related articles for article (PubMed ID: 7515197)
1. Prostate cancer screening before and after abdominoperineal resection: recommendations, biopsy, and therapeutic techniques.
Pérez LM; Mekras JA; Neshat AA; Weems WS; Shook EL
Surgery; 1994 Jun; 115(6):745-50. PubMed ID: 7515197
[TBL] [Abstract][Full Text] [Related]
2. Transperineal prostate needle biopsy guided by transurethral ultrasound in patients without a rectum.
Seaman EK; Sawczuk IS; Fatal M; Olsson CA; Shabsigh R
Urology; 1996 Mar; 47(3):353-5. PubMed ID: 8633401
[TBL] [Abstract][Full Text] [Related]
3. Prostate biopsy after abdominoperineal resection: a diagnostic challenge.
Morlacco A; Bierti S; Abbinante M; Frea B; Crivellaro S
Urologia; 2013; 80(3):244-6. PubMed ID: 23813284
[TBL] [Abstract][Full Text] [Related]
4. Incidence and variables predicting Gleason score up-grading between trans-rectal ultrasound-guided prostate biopsies and radical prostatectomy.
Bright E; Manuel C; Goddard JC; Khan MA
Urol Int; 2010; 84(2):180-4. PubMed ID: 20215822
[TBL] [Abstract][Full Text] [Related]
5. [The role of the absolute value and "density" of the prostate-specific antigen estimated echographically in the selection of patients to undergo a biopsy in suspected prostatic carcinoma. A comparison between PSA, palpation and echography in 95 patients undergoing echo-guided endorectal prostatic biopsy].
Di Donna A; Bazzocchi M; Guerra UP; Bendini M; De Biasi F; Caminiti F; Delendi M
Radiol Med; 1993; 85(1-2):84-9. PubMed ID: 7683136
[TBL] [Abstract][Full Text] [Related]
6. [Predictive value of prostate specific antigen density in the detection of prostate cancer in patients with elevated prostate specific antigen levels and normal digital rectal findings or stage A prostate cancer].
Iwaki H; Kajita Y; Shimizu Y; Yamauchi T
Hinyokika Kiyo; 2001 Mar; 47(3):169-74. PubMed ID: 11329957
[TBL] [Abstract][Full Text] [Related]
7. Preoperative serum prostate specific antigen levels between 2 and 22 ng./ml. correlate poorly with post-radical prostatectomy cancer morphology: prostate specific antigen cure rates appear constant between 2 and 9 ng./ml.
Stamey TA; Johnstone IM; McNeal JE; Lu AY; Yemoto CM
J Urol; 2002 Jan; 167(1):103-11. PubMed ID: 11743285
[TBL] [Abstract][Full Text] [Related]
8. Measurement of prostate-specific antigen in serum as a screening test for prostate cancer.
Catalona WJ; Smith DS; Ratliff TL; Dodds KM; Coplen DE; Yuan JJ; Petros JA; Andriole GL
N Engl J Med; 1991 Apr; 324(17):1156-61. PubMed ID: 1707140
[TBL] [Abstract][Full Text] [Related]
9. Results of a screening program for prostate cancer in patients scheduled for abdominoperineal resection for colorectal pathologic findings.
Terris MK; Wren SM
Urology; 2001 May; 57(5):943-5. PubMed ID: 11337299
[TBL] [Abstract][Full Text] [Related]
10. Transperineal prostate biopsy after abdominoperineal resection.
Shinohara K; Gulati M; Koppie T; Terris MK
J Urol; 2003 Jan; 169(1):141-4. PubMed ID: 12478122
[TBL] [Abstract][Full Text] [Related]
11. [The digital rectal exam, prostate-specific antigen and transrectal echography in the diagnosis of prostatic cancer].
Martínez de Hurtado J; Chéchile Toniolo G; Villavicencio Mavrich H
Arch Esp Urol; 1995 Apr; 48(3):247-59. PubMed ID: 7538749
[TBL] [Abstract][Full Text] [Related]
12. Transperineal template-guided prostate biopsy for patients with persistently elevated PSA and multiple prior negative biopsies.
Gershman B; Zietman AL; Feldman AS; McDougal WS
Urol Oncol; 2013 Oct; 31(7):1093-7. PubMed ID: 22305626
[TBL] [Abstract][Full Text] [Related]
13. Biopsy indication--a predictor of pathologic stage among men with preoperative serum PSA levels of 4.0 ng/mL or less and T1c disease.
Freedland SJ; Mangold LA; Epstein JI; Partin AW
Urology; 2004 May; 63(5):887-91. PubMed ID: 15134972
[TBL] [Abstract][Full Text] [Related]
14. Immediate radical prostatectomy in patients with atypical small acinar proliferation. Over treatment?
Brausi M; Castagnetti G; Dotti A; De Luca G; Olmi R; Cesinaro AM
J Urol; 2004 Sep; 172(3):906-8; discussion 908-9. PubMed ID: 15310995
[TBL] [Abstract][Full Text] [Related]
15. Optimized strategy for detection of early stage, curable prostate cancer: role of prescreening with prostate-specific antigen.
Labrie F; Dupont A; Suburu R; Cusan L; Gomez JL; Koutsilieris M; Diamond P; Emond J; Lemay M; Candas B
Clin Invest Med; 1993 Dec; 16(6):425-39. PubMed ID: 7516831
[TBL] [Abstract][Full Text] [Related]
16. [Value of free PSA/total PSA ratio in therapeutic decisions in the case of a single positive biopsy of the prostate].
Huyghe E; Soulie M; Tollon C; Escourrou G; Pontonnier F; Plante P
Prog Urol; 1999 Apr; 9(2):281-7. PubMed ID: 10370952
[TBL] [Abstract][Full Text] [Related]
17. Prostatic ultrasound in the patient without a rectum.
Filderman PS; Jacobs SC
Urology; 1994 May; 43(5):722-4. PubMed ID: 8165775
[TBL] [Abstract][Full Text] [Related]
18. Prostatic transition zone biopsies in men with previous negative biopsies and persistently elevated serum prostate specific antigen values.
Keetch DW; Catalona WJ
J Urol; 1995 Nov; 154(5):1795-7. PubMed ID: 7563349
[TBL] [Abstract][Full Text] [Related]
19. Detection of prostatic carcinoma: the role of TRUS, TRUS guided biopsy, digital rectal examination, PSA and PSA density.
Men S; Cakar B; Conkbayir I; Hekimoglu B
J Exp Clin Cancer Res; 2001 Dec; 20(4):473-80. PubMed ID: 11876539
[TBL] [Abstract][Full Text] [Related]
20. Value of prostate-specific antigen (PSA) mass ratio in the detection of prostate cancer in men with PSA levels of ≤10 ng/mL.
Hong SK; Oh JJ; Byun SS; Hwang SI; Choo MS; Lee SE
BJU Int; 2012 Jul; 110(2 Pt 2):E81-5. PubMed ID: 22093144
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
